TWP
GILD icon

Tempus Wealth Planning’s Gilead Sciences GILD Stock Holding History

Tempus Wealth Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$1K – 85
2020
Q3 		$1K Buy
+5,000
New +$347K ﹤0.01% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tempus Wealth Planning's GILD Position: Q1 2026 in Review

Tempus Wealth Planning increased its Gilead Sciences (GILD) stake by 3.6% in Q1 2026, buying an estimated $9.24K and bringing the position to 1,900 shares worth $265K. The position accounts for 0.06% of the portfolio, ranked #233.

Tempus Wealth Planning first reported a position in GILD in Q3 2020 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Tempus Wealth Planning held 1,900 shares of Gilead Sciences worth $265K as of Q1 2026.
  • Tempus Wealth Planning bought 66 Gilead Sciences shares in Q1 2026, an estimated $9.24K.
  • Gilead Sciences made up 0.06% of Tempus Wealth Planning's portfolio in Q1 2026, its #233 holding.
  • Tempus Wealth Planning first reported a position in Gilead Sciences in Q3 2020 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Tempus Wealth Planning's 13F filing for Q1 2026, filed 29 Apr 2026.